Daiichi Sankyo Acquires U.S. Generic Injectables Maker PharmaForce
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Daiichi Sankyo's U.S. subsidiary, Luitpold Pharmaceutical of New York has fully acquired PharmaForce of Columbus, Ohio, a specialty injectable pharmaceutical company, the Tokyo-based company said